Evaluating Clinical Pathways for Ovarian Cancer Treatment and Maintenance Therapy

imedex has 1334 videos Subscribe Here

Description: Earn CME credit for this activity:

This on-demand activity examines the implications of BRCA mutational status, BRCAness, synthetic lethality, and within-class differences in the mechanisms of action, efficacy and safety, and indications of available and emerging PARP inhibitors for optimal ovarian cancer pathway integration.

© 2018 NACCME, an HMP Company
Shared By : imedex
Posted on : 03/06/19
Added : 5 months ago
Category : Ovarian Cancer